{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:38:37Z","timestamp":1790177917631,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["1021264"],"award-info":[{"award-number":["1021264"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R15DK137195"],"award-info":[{"award-number":["R15DK137195"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cellsig.2025.111749","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T06:39:08Z","timestamp":1742107148000},"page":"111749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Activation of toll-like receptor 2 promotes the expression of inflammatory mediators and cell proliferation of human polycystic kidney disease cells"],"prefix":"10.1016","volume":"131","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Plansinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Peak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Leagjeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren P.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0005","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"14","key":"10.1016\/j.cellsig.2025.111749_bb0010","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111749_bb0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0020","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","article-title":"Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease","volume":"14","author":"Zheng","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111749_bb0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2025.111749_bb0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and fibrosis in polycystic kidney disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl. Cell Differ."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0035","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.1986.116","article-title":"Accelerated renal cyst development in deconditioned germ-free rats","volume":"29","author":"Gardner","year":"1986","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111749_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ki.1987.213","article-title":"Endotoxin provocation of experimental renal cystic disease","volume":"32","author":"Gardner","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2025.111749_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109647","article-title":"Role of chemokines, innate and adaptive immunity","volume":"73","author":"Zimmerman","year":"2020","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0050","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0055","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","article-title":"Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease","volume":"29","author":"Cassini","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1369\/0022155417740880","article-title":"Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity","volume":"66","author":"Frevert","year":"2018","journal-title":"J. Histochem. Cytochem."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0070","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2014010117","article-title":"Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis","volume":"25","author":"Anders","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0075","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury","volume":"117","author":"Wu","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111749_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037584","article-title":"TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis","volume":"7","author":"Castoldi","year":"2012","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0085","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI22832","article-title":"Renal-associated TLR2 mediates ischemia\/reperfusion injury in the kidney","volume":"115","author":"Leemans","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111749_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MNH.0b013e32832a1d5f","article-title":"Toll-like receptors in kidney disease","volume":"18","author":"Smith","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111749_bb0095","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.168.3.1286","article-title":"In vivo expression of toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation","volume":"168","author":"Wolfs","year":"2002","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2012.08.010","article-title":"STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation","volume":"22","author":"Tye","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001393","article-title":"Microbial patterns signaling via toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival","volume":"3","author":"Shaykhiev","year":"2008","journal-title":"PloS One"},{"issue":"5244","key":"10.1016\/j.cellsig.2025.111749_bb0110","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","article-title":"Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction","volume":"270","author":"Yamaguchi","year":"1995","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.cellsig.2025.111749_bb0115","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200099","article-title":"TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases","volume":"10","author":"Totzke","year":"2020","journal-title":"Open Biol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tips.2012.06.007","article-title":"Targeting of TAK1 in inflammatory disorders and cancer","volume":"33","author":"Sakurai","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells5010012","article-title":"The regulation of NF-kappaB subunits by phosphorylation","volume":"5","author":"Christian","year":"2016","journal-title":"Cells"},{"issue":"2\u20133","key":"10.1016\/j.cellsig.2025.111749_bb0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0014-5793(00)01146-7","article-title":"TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages","volume":"467","author":"Irie","year":"2000","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1744-9987.12458","article-title":"Toll-like receptors in the progression of autosomal dominant polycystic kidney disease","volume":"20","author":"Kocyigit","year":"2016","journal-title":"Ther. Apher. Dial."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0140","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2215\/CJN.01870309","article-title":"Cyst infections in patients with autosomal dominant polycystic kidney disease","volume":"4","author":"Sallee","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2025.111749_bb0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","article-title":"Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease","volume":"47","author":"Leonhard","year":"2019","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0150","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0155","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2025.111749_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.mcb.2019.05.005","article-title":"Generation of primary cells from ADPKD and normal human kidneys","volume":"153","author":"Wallace","year":"2019","journal-title":"Methods Cell Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0165","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1681\/ASN.2015010047","article-title":"Phosphodiesterase isoform regulation of cell proliferation and fluid secretion in autosomal dominant polycystic kidney disease","volume":"27","author":"Pinto","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2025.111749_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcp.2017.11.012","article-title":"Exogenous oxidants activate nuclear factor kappa B through toll-like receptor 4 stimulation to maintain inflammatory phenotype in macrophage","volume":"147","author":"Zhang","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcp.2015.08.109","article-title":"Toll-like receptor 4 signaling: a common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation","volume":"98","author":"Zhang","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac050","article-title":"CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation","volume":"14","author":"Zhang","year":"2022","journal-title":"J. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111749_bb0185","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0190","doi-asserted-by":"crossref","first-page":"F1135","DOI":"10.1152\/ajprenal.00366.2020","article-title":"Overexpression of TGF-beta1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease","volume":"319","author":"Zhang","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111749_bb0195","doi-asserted-by":"crossref","first-page":"F1005","DOI":"10.1152\/ajprenal.00243.2011","article-title":"Tolvaptan inhibits ERK-dependent cell proliferation, Cl(\u2212) secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin","volume":"301","author":"Reif","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"14","key":"10.1016\/j.cellsig.2025.111749_bb0200","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0205","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111749_bb0210","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2011030277","article-title":"c-Met and NF-kappaB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease","volume":"23","author":"Qin","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5527\/wjn.v5.i4.339","article-title":"Constitutive renal Rel\/nuclear factor-kappaB expression in Lewis polycystic kidney disease rats","volume":"5","author":"Ta","year":"2016","journal-title":"World J Nephrol"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0220","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1006\/bbrc.2001.4883","article-title":"Cytokine-induced stabilization of newly synthesized I(kappa)B-alpha","volume":"283","author":"Place","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0225","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.kint.2021.01.028","article-title":"The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1(RC\/RC) mouse model of autosomal dominant polycystic kidney disease","volume":"99","author":"Arroyo","year":"2021","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0230","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI41531","article-title":"Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease","volume":"120","author":"Qin","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"38","key":"10.1016\/j.cellsig.2025.111749_bb0235","doi-asserted-by":"crossref","first-page":"36916","DOI":"10.1074\/jbc.M301598200","article-title":"Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway","volume":"278","author":"Sakurai","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111749_bb0240","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10157-020-01928-2","article-title":"Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues","volume":"24","author":"Suwabe","year":"2020","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.cellsig.2025.111749_bb0245","article-title":"Inflammatory cytokine levels in patients with autosomal dominant polycystic kidney disease (ADPKD)","volume":"360","author":"Arjune","year":"2024","journal-title":"Kidney"},{"key":"10.1016\/j.cellsig.2025.111749_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.971219","article-title":"Caspase-1 and the inflammasome promote polycystic kidney disease progression","volume":"9","author":"Swenson-Fields","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.08.010","article-title":"Toll-like receptor signaling in cell proliferation and survival","volume":"49","author":"Li","year":"2010","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0260","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111749_bb0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"issue":"7260","key":"10.1016\/j.cellsig.2025.111749_bb0270","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature08247","article-title":"Direct activation of protein kinases by unanchored polyubiquitin chains","volume":"461","author":"Xia","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.111749_bb0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2017.06.009","article-title":"TAK1 as the mediator in the protective effect of propofol on renal interstitial fibrosis induced by ischemia\/reperfusion injury","volume":"811","author":"Wu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0280","doi-asserted-by":"crossref","first-page":"F1410","DOI":"10.1152\/ajprenal.00018.2011","article-title":"TGF-beta1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney","volume":"300","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0285","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00516.2019","article-title":"TAK1 deficiency attenuates cisplatin-induced acute kidney injury","volume":"318","author":"Zhou","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111749_bb0290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111749_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-alpha) in autoimmune disease and current TNF-alpha inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111749_bb0300","first-page":"1153","article-title":"Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)","volume":"13","author":"Lanoix","year":"1996","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.cellsig.2025.111749_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512464","article-title":"An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes","volume":"24","author":"Colleselli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0310","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ni809","article-title":"Essential role of MD-2 in LPS responsiveness and TLR4 distribution","volume":"3","author":"Nagai","year":"2002","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111749_bb0315","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.4049\/jimmunol.165.7.3541","article-title":"Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B","volume":"165","author":"Jiang","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111749_bb0320","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jiv270","article-title":"Toll-like receptor 10 in Helicobacter pylori infection","volume":"212","author":"Nagashima","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111749_bb0325","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2249.2006.03116.x","article-title":"Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products","volume":"145","author":"Chowdhury","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111749_bb0330","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1096\/fj.11-195396","article-title":"Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury","volume":"26","author":"Farrar","year":"2012","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111749_bb0335","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.chembiol.2017.07.011","article-title":"Takinib, a selective TAK1 inhibitor, broadens the therapeutic efficacy of TNF-alpha inhibition for cancer and autoimmune disease","volume":"24","author":"Totzke","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111749_bb0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1021\/acschembio.1c00788","article-title":"Development and efficacy of an orally bioavailable selective TAK1 inhibitor for the treatment of inflammatory arthritis","volume":"17","author":"Scarneo","year":"2022","journal-title":"ACS Chem. Biol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:46:04Z","timestamp":1744371964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825001627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"alternative-id":["S0898656825001627"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111749","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of toll-like receptor 2 promotes the expression of inflammatory mediators and cell proliferation of human polycystic kidney disease cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111749"}}